Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I (Tumour Site Specific) Study of Carboplatin and Temozolomide in Patients With Advanced Melanoma

NCT00003747 is registered in ClinicalTrials.gov with Mount Vernon Cancer Centre at Mount Vernon Hospital as lead sponsor.

NCT NCT00003747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I (Tumour Site Specific) Study of Carboplatin and Temozolomide in Patients With Advanced Melanoma
Lead sponsor
Mount Vernon Cancer Centre at Mount Vernon Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
October 31, 1998
Completion date
Not reported
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin)